Literature DB >> 28658801

Hypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar Rats.

Dheeraj Kumar Singh1, Narendra Kumar2, Anjula Sachan3, Preet Lakhani1, Sachin Tutu1, Rajendra Nath4, Amod Kumar Sachan4, Rakesh Kumar Dixit4.   

Abstract

INTRODUCTION: Hyperlipidaemia is a well known risk factor for cardiovascular diseases. Lifestyle modification can be the initial step to reduce cholesterol levels. There are various drugs which are used to control dyslipidaemia. Treatment of lipid abnormalities is a lifelong battle. Moreover, the safety and effectiveness of long term lipid lowering treatment are questionable. Gymnema Sylvestre (GS) is a well known herb with various medicinal properties. AIM: To explore the hypolipidaemic activity of GS leaves extract.
MATERIALS AND METHODS: Adult healthy female wistar rats, 30 in number, divided into five groups, weighing 150- 200 g were used. Dyslipidaemia was induced in rats by feeding them on high fat diet for four weeks. For the next four weeks GS extract was used as test drug while Atorvastatin was used as standard drug. Blood sample was collected for estimation of lipid profile on day 0, week 4 and week 8. Data was recorded as mean±SEM (Standard error of mean). Paired t-test and one way Analysis of Variance (ANOVA) followed by Dunnett's post hoc test was used for comparison. A p-value <0.05 was considered statistically significant. SPSS Statistics 20 (IBM software) was used for the analysis.
RESULTS: Feeding rats with high fat diet for four weeks led to obesity and dyslipidaemia in rats. GS at both the doses (100mg/kg and 200mg/kg) significantly improved the lipid profile. Total Cholesterol (TC), Triglycerides (TG), Very Low Density Lipoprotein (VLDL) and Low Density Lipoprotein (LDL) values reduced significantly while that of High Density Lipoprotein (HDL) increased significantly. GS 200 mg/kg was found more effective than GS 100 mg/kg. GS improved the value of lipid profile significantly but the effect was found inferior to Atorvastatin.
CONCLUSION: From the present study it can be concluded that GS possess an effective hypolipidaemic effect. Hence it can be included as an add on therapy in dyslipidaemia after further confirmatory studies.

Entities:  

Keywords:  Cholesterol; Extract; Lipid profile

Year:  2017        PMID: 28658801      PMCID: PMC5483703          DOI: 10.7860/JCDR/2017/27430.9859

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

Review 1.  Hyperlipidemia: diagnostic and therapeutic perspectives.

Authors:  C M Ballantyne; S M Grundy; A Oberman; R A Kreisberg; R J Havel; P H Frost; S M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Dyslipidaemia.

Authors:  Paul Durrington
Journal:  Lancet       Date:  2003-08-30       Impact factor: 79.321

4.  Increased ApoB in small dense LDL particles predicts premature coronary artery disease.

Authors:  John D Brunzell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03       Impact factor: 8.311

Review 5.  Hypertriglyceridaemia in diabetes.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2006-12-16

6.  Gurmarin inhibition of sweet taste responses in mice.

Authors:  Y Ninomiya; T Imoto
Journal:  Am J Physiol       Date:  1995-04

7.  Suppression of glucose absorption by some fractions extracted from Gymnema sylvestre leaves.

Authors:  K Shimizu; A Iino; J Nakajima; K Tanaka; S Nakajyo; N Urakawa; M Atsuchi; T Wada; C Yamashita
Journal:  J Vet Med Sci       Date:  1997-04       Impact factor: 1.267

8.  Inhibitory effect of gurmarin on palatal taste responses to amino acids in the rat.

Authors:  S Harada; Y Kasahara
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-06       Impact factor: 3.619

Review 9.  Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithm.

Authors:  Allan D Sniderman
Journal:  Curr Opin Lipidol       Date:  2004-08       Impact factor: 4.776

10.  Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats.

Authors:  G Dilip Reddy; A Gopala Reddy; G S Rao; M Vijay Kumar
Journal:  Indian J Pharmacol       Date:  2012-03       Impact factor: 1.200

View more
  2 in total

1.  Erchen Decoction Ameliorates Lipid Metabolism by the Regulation of the Protein CAV-1 and the Receptors VLDLR, LDLR, ABCA1, and SRB1 in a High-Fat Diet Rat Model.

Authors:  Shanshan Ding; Jie Kang; Ling Tong; Yuchen Lin; Linghong Liao; Bizhen Gao
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

Review 2.  Comprehensive Review on Phytochemicals, Pharmacological and Clinical Potentials of Gymnema sylvestre.

Authors:  Farzana Khan; Md Moklesur Rahman Sarker; Long Chiau Ming; Isa Naina Mohamed; Chao Zhao; Bassem Y Sheikh; Hiew Fei Tsong; Mohammad A Rashid
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.